1. Nakamura Y, Yamazaki Y, Felizola SJ, et al. Adrenocortical carcinoma.: Review of the pathologic features, production of adrenal steroids, and molecular pathogenesis. Endocrinology and Metabolism Clinics of North America. 2015;44(2):399–410. https://doi.org/10.1016/j.ecl.2015.02.007

2. Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison's principles of internal medicine, 21st ed. New York: McGraw Hill Education; 2021.

3. Melmed S, Auchus RJ, Goldfine AB, Koenig RJ, Rosen CJ. Williams textbook of endocrinology, 14th ed. Philadelphia: Elsevier; 2020.

4. Libé R, Huillard O. Adrenocortical carcinoma: Diagnosis, prognostic classification and treatment of localized and advanced disease. Cancer Treat Res Commun. 2023;37:100759. https://pubmed.ncbi.nlm.nih.gov/37690343 https://doi.org/10.1016/j.ctarc.2023.100759

5. Wagner-Bartak NA, Baiomy A, Habra MA, et al. Cushing syndrome: Diagnostic workup and imaging features, with clinical and pathologic correlation. Am J Roentgenol. 2017;209(1):19–32. https://pubmed.ncbi.nlm.nih.gov/28639924 https://doi.org/10.2214/AJR.16.17290

6. Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: Case detection, diagnosis, and treatment: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(5):1889–916. https://pubmed.ncbi.nlm.nih.gov/26934393 https://doi.org/ 10.1210/jc.2015-4061

7. Rossi GP, Auchus RJ, Brown M, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension. 2014;63(1):151–60. https://pubmed.ncbi.nlm.nih.gov/24218436 https://doi.org/10.1161/HYPERTENSIONAHA.113.02097

8. He X, Peter PR, Auchus RJ. Approach to the patient with an incidental adrenal mass. Med Clin North Am. 2021;105(6):1047-63. https://pubmed.ncbi.nlm.nih.gov/34688414 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984966 https://doi.org/10.1016/j.mcna.2021.06.009

9. Fassnacht M, Dekkers OM, Else T. et al. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2018;179(4):G1-46. https://pubmed.ncbi.nlm.nih.gov/30299884 https://doi.org/10.1530/EJE-18-0608

10. Kiseljak-Vassiliades K, Bancos I, Hamrahian A, et al. American Association of Clinical Endocrinology Disease State Clinical Review on the evaluation and management of adrenocortical carcinoma in an adult: a practical approach. Endocr Pract. 2020;26(11):1366-83. https://pubmed.ncbi.nlm.nih.gov/33875173 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058447 https://doi.org/10.4158/DSCR-2020-0567